Building the infrastructure layerfor tech-enabled drug discovery
We are the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation.
We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer.